Amy holds an honours degree and a PhD in molecular biology from UQ. Her early postdoctoral work focused on understanding the genetic basis of colorectal cancer using experimental disease models, as part of a Cancer Research UK-funded colorectal cancer program led by Professors Ian Tomlinson and Andrew Silver.
After returning to Australia in 2009, she was recruited to the Molecular Breast Pathology group as a molecular genetics specialist. She is passionate about clinical research and biobanking, and in addition to her breast cancer research portfolio she coordinates the Brisbane Breast Bank and the Brisbane node of the BROCADE autopsy study.
Breast cancer is an incredibly diverse disease, encompassing many different types of tumours. While outcomes have improved for the majority of patients, there is much we can do to improve outcomes for those with poorer prognoses. Unfortunately, it remains difficult to predict the risk of the disease returning and/or spreading, and whether a patient will respond to a specific therapy. Genomic and genetic analyses will help to improve tumour characterisation, and identify predictive and prognostic biomarkers.